Pfizer India speaks up after Karnataka FDA crackdown, says patient safety is top priority
viaeconomictimes.indiatimes.com23 Sept
Pfizer India has stated that patient safety and product quality are their top priorities following FDA actions. The Karnataka FDA canceled 16 drug licenses and suspended eight othe
Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to economictimes.indiatimes.com's own reporting rather than reproducing it — the excerpt above comes from economictimes.indiatimes.com's own feed.
Read the full story on economictimes.indiatimes.com ↗